NEW YORK (Reuters Health) – An “evolving concept” in the treatment of inflammatory bowel disease is to use biologic agents to obviate long-term treatment with steroids, according to…
NEW YORK (Reuters Health) – Results of a meta-analysis indicate that antenatal steroids seem safe and reduce adverse outcomes in preterm infants when the pregnancy is complicated by…
NEW YORK (Reuters Health) – Updated guidelines compiled by an expert panel of cardiologists and gastroenterologists address the issue of a possible drug interaction between proton pump inhibitors…
NEW YORK (Reuters Health) – Short-term testosterone treatment in frail elderly men improves muscle mass and strength, but the effects don’t last more than 6 months after treatment…
NEW YORK (Reuters Health) – The tyrosine kinase inhibitors gefitinib or erlotinib may slow the development of central nervous system metastases in patients with advanced non-small cell lung…
NEW YORK (Reuters Health) – When children develop a skin rash after being treated with a beta-lactam, the cause is more likely to be related to a viral…
NEW YORK (Reuters Health) – The question of when to resume warfarin therapy after a patient has an intracranial hemorrhage is answered in the December issue of Stroke.…
NEW YORK (Reuters Health) – Very elderly patients, perhaps up to 100 years old, with acute ischemic stroke benefit from timely thrombolytic therapy to the same degree as…
NEW YORK (Reuters Health) – After first-line treatment with bevacizumab plus interferon-alpha2a, subsequent therapy with tyrosine kinase inhibitors (TKIs) improves survival in patients with metastatic renal cell carcinoma,…
NEW YORK (Reuters Health) – Patients with major depressive disorder respond faster to treatment with citalopram when given pindolol concomitantly, and the strategy also increases the rate of…